How shall we treat early triple-negative breast cancer (TNBC): from the current standard to upcoming immuno-molecular strategies
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference159 articles.
1. [Triple negative breast cancer: a difficult disease to diagnose and treat];Zaharia;Rev Peru Med Exp Salud Publica,2013
2. Triple-negative breast carcinoma: current and emerging concepts;Schmadeka;Am J Clin Pathol,2014
3. Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up;Malorni;Breast Cancer Res Treat,2012
4. Relapsed triple-negative breast cancer: challenges and treatment strategies;Guarneri;Drugs,2013
5. Triple-negative breast cancers: unique clinical presentations and outcomes;Billar;Ann Surg Oncol,2010
Cited by 119 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting overexpressed surface proteins: A new strategy to manage the recalcitrant triple-negative breast cancer;European Journal of Pharmacology;2024-10
2. Recent Advances in Immunotherapy and Targeted Therapy of Triple Negative Breast Cancer;Current Pharmaceutical Biotechnology;2024-07-31
3. Dual-targeted nanoparticulate drug delivery systems for enhancing triple-negative breast cancer treatment;Journal of Controlled Release;2024-07
4. Priming with oncolytic adenovirus followed by anti-PD-1 and paclitaxel treatment leads to improved anti-cancer efficacy in the 3D TNBC model;European Journal of Pharmaceutics and Biopharmaceutics;2024-06
5. Sulfatase-Induced In Situ Formulation of Antineoplastic Supra-PROTACs;Journal of the American Chemical Society;2024-04-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3